🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a multicenter, open label, randomized phase II study to evaluate t...
Status
Terminated
Location
Cedars Sinai Medical Center SC-3
Start Date
2012-10
Trial ID
NCT01628913
Treatments Being Tested
In this study, BEZ235 will be administered to adult patients with advanced ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-10
Trial ID
NCT01195376
Treatments Being Tested
The purpose of this study is to determine if RTB101 prevents illness associ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-10-21
Trial ID
NCT04139915
Treatments Being Tested
The purpose of the trial is to determine the maximum tolerated dose (MTD) o...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-01
Trial ID
NCT01285466
This is an open label study of abiraterone acetate in combination with BEZ2...
Status
Completed
Location
Cedars Sinai Medical Center SC
Start Date
2012-09
Trial ID
NCT01634061
This study tests a new medication for treatment of kidney cancer, called BE...
Status
Terminated
Location
Memorial Sloan Kettering Cancer Center
Start Date
2011-10
Trial ID
NCT01453595
Treatments Being Tested
Primary objectives: * To establish the maximum tolerated dose (MTD), and t...
Status
Completed
Location
Johann Wolfgang Goethe University Hospitals
Start Date
2012-06
Trial ID
NCT01756118
Treatments Being Tested
This is a prospective, multi-center, open-label, single arm, phase II study...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01288092
Treatments Being Tested
This is an open label, dose finding, phase Ib clinical trial to determine t...
Status
Completed
Location
Massachusetts General Hospital Mass General 2
Start Date
2011-07-08
Trial ID
NCT01337765
Treatments Being Tested
It is known that after application of MK-3475 activated PD -1 negatively re...
Status
Unknown
Location
Dana-Farber Cancer Institute
Start Date
2013-03
Trial ID
NCT02430363
Treatments Being Tested